Publication in refereed journal
香港中文大学研究人员 ( 现职)
| 莫树锦教授 (肿瘤学系) |
| 杨明明教授 (肿瘤学系) |
| 何施明教授 (影像及介入放射学系) |
全文
| 数位物件识别号 (DOI) http://dx.doi.org/10.1159/000081005 |
引用次数
Web of Sciencehttp://aims.cuhk.edu.hk/converis/portal/Publication/21WOS source URL
其它资讯
摘要A woman with stage IIIb non-small cell lung cancer (NSCLC) developed disease progression with brain metastases during chemotherapy. Due to unusual circumstances, the patient received gefitinib alone, without the use of corticosteroid treatment or radiotherapy. There was a dramatic clinical improvement within 1 week. Followup magnetic resonance imaging of the brain 1 month later showed decreases in both the size and number of brain metastases. The patient remains well 9 months after initiation of gefitinib. It is proposed that gefitinib may have a role in treatment of brain metastases from NSCLC. Copyright (C) 2004 S. Karger AG, Basel.
着者Poon ANY, Ho SSM, Yeo W, Mok TSK
期刊名称ONCOLOGY
出版年份2004
月份1
日期1
卷号67
期次2
出版社KARGER
页次174 - 178
国际标準期刊号0030-2414
语言英式英语
关键词brain metastases; chemotherapy; gefitinib; lung cancer; metastases; radiotherapy
Web of Science 学科类别Oncology; ONCOLOGY
